Ultrasound reflections fail to reflect the histopathology of the prostateTOBOCMAN, W; RESNICK, M. I; PRETLOW, T. G et al.The Prostate. 1997, Vol 30, Num 1, pp 33-40, issn 0270-4137Article

Enzyme histochemistry of monocytes/macrophages: a study in a murine model of immune complex-mediated glomerulonephritisISKANDAR, S. S; EMANCIPATOR, S. N; PRETLOW, T. G. II et al.The Journal of histochemistry and cytochemistry. 1989, Vol 37, Num 1, pp 25-29, issn 0022-1554Article

Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancerDAWSON, D. M; LAWRENCE, E. G; MACLENNAN, G. T et al.Journal of the National Cancer Institute. 1998, Vol 90, Num 7, pp 519-523, issn 0027-8874Article

Histocultures of human prostate tissues for pharmacologic evaluationWIENTJES, M. G; PRETLOW, T. G; BADALAMENT, R. A et al.The Journal of urology. 1995, Vol 153, Num 4, pp 1299-1302, issn 0022-5347Article

Xenografts of primary human prostatic carcinomaPRETLOW, T. G; WOLMAN, S. R; PRETLOW, T. P et al.Journal of the National Cancer Institute. 1993, Vol 85, Num 5, pp 394-398, issn 0027-8874Article

A novel approach to the characterization of whole prostate pathology in glycol methacrylateMONGER, L. E; NAGABHUSHAN, M; PRETLOW, T. G et al.The American journal of pathology. 1994, Vol 145, Num 1, pp 54-60, issn 0002-9440Article

Study of activities of arginase, hexosaminidase, and leucine aminopeptide in prostate fluidVAFA, A. Z; GROVER, P. K; PRETLOW, T. G et al.Urology (Ridgewood, NJ). 1993, Vol 42, Num 2, pp 138-143, issn 0090-4295Article

High-resolutioin analyses of two different classes of tumor cells in situ tagged with alternative histochemical marker genesWEN-CHANG LIN; PRETLOW, T. P; PRETLOW, T. G et al.The American journal of pathology. 1992, Vol 141, Num 6, pp 1331-1342, issn 0002-9440Article

Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasiaPRETLOW, T. G; PRETLOW, T. P; BIN YANG et al.International journal of cancer. 1991, Vol 49, Num 5, pp 645-649, issn 0020-7136Article

Molecular cytogenetic studies of a serially transplanted primary prostatic carcinoma xenograft (CWR22) and four relapsed tumorsKOCHERA, M; DEPINET, T. W; PRETLOW, T. P et al.The Prostate. 1999, Vol 41, Num 1, pp 7-11, issn 0270-4137Article

The identification of monoclonality in human aberrant crypt fociSIU, I.-M; ROBINSON, D. R; SCHWARTZ, S et al.Cancer research (Baltimore). 1999, Vol 59, Num 1, pp 63-66, issn 0008-5472Article

Evidence of independent origin of multiple tumors from patients with prostate cancerLIANG CHENG; SONG, S.-Y; EMMERT-BUCK, M. R et al.Journal of the National Cancer Institute. 1998, Vol 90, Num 3, pp 233-237, issn 0027-8874Article

The cooperative human tissue network : an updateLIVOLSI, V. A; CLAUSEN, K. P; GRIZZLE, W et al.Cancer. 1993, Vol 71, Num 4, pp 1391-1394, issn 0008-543XArticle

Recovery of nuclei from glycol-methacrylate-embedded tissueTHORBURN WRIGHT, E; JACOBBERGER, J. W; PRETLOW, T. P et al.Blood. 1990, Vol 76, Num 8, pp 1622-1625, issn 0006-4971Article

5'-Nucleotidase activity in prostatic carcinoma and benign prostatic hyperplasiaRACKLEY, R. R; LEWIS, T. J; PRESTON, E. M et al.Cancer research (Baltimore). 1989, Vol 49, Num 13, pp 3702-3707, issn 0008-5472Article

Changes in cyclin dependent kinase inhibitors p21 and p27 during the castration induced regression of the CWR22 model of prostatic adenocarcinomaMYERS, R. B; OELSCHLAGER, D. K; COAN, P. N et al.The Journal of urology. 1999, Vol 161, Num 3, pp 945-949, issn 0022-5347Article

Hormone therapy failure in human prostate cancer : Analysis by complementary DNA and tissue microarraysBUBENDORF, L; KOLMER, M; ELKAHLOUN, A. G et al.Journal of the National Cancer Institute. 1999, Vol 91, Num 20, pp 1758-1764, issn 0027-8874Article

Workgroup 2: Human xenograft models of prostate cancerSTEARNS, M. E; WARE, J. L; PRETLOW, T. G et al.The Prostate. 1998, Vol 36, Num 1, pp 56-58, issn 0270-4137Conference Paper

Identification of dysplasia in human colonic aberrant crypt fociSIU, I.-M; PRETLOW, T. G; AMINI, S. B et al.The American journal of pathology. 1997, Vol 150, Num 5, pp 1805-1813, issn 0002-9440Article

Human aberrant crypt foci with carcinoma in situ from a patient with sporadic colon cancerKONSTANTAKOS, A. K; SIU, I.-M; PRETLOW, T. G et al.Gastroenterology (New York, NY. 1943). 1996, Vol 111, Num 3, pp 772-777, issn 0016-5085Article

Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytatePRETLOW, T. P; O'RIORDAN, M. A; SOMICH, G. A et al.Carcinogenesis (New York. Print). 1992, Vol 13, Num 9, pp 1509-1512, issn 0143-3334Article

Bacterial lacZ gene as a highly sensitive marker to detect micrometastasis formation during tumor progressionWEN-CHANG LIN; PRETLOW, T. P; PRETLOW, T. G et al.Cancer research (Baltimore). 1990, Vol 50, Num 9, pp 2808-2817, issn 0008-5472, 10 p.Article

Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesionsXING PEI HAO; WILLIS, J. E; PRETLOW, T. G et al.Cancer research (Baltimore). 2000, Vol 60, Num 1, pp 18-21, issn 0008-5472Article

CWR22 xenograft as an ex vivo human tumor model for prostate cancer gene therapyCHENG, L; SUN, J; PRETLOW, T. G et al.Journal of the National Cancer Institute. 1996, Vol 88, Num 9, pp 607-611, issn 0027-8874Article

Expression of E-cadherin in primary and metastatic prostate cancerLIANG CHENG; MOOLKY NAGABHUSHAN; PRETLOW, T. P et al.The American journal of pathology. 1996, Vol 148, Num 5, pp 1375-1380, issn 0002-9440Article